Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms RESPONSE

被引:11
|
作者
Hultcrantz, Malin [1 ,2 ]
Bjorkholm, Magnus [1 ,2 ]
Landgren, Ola [3 ]
Kristinsson, Sigurdur Y. [4 ,5 ]
Andersson, Therese M. L. [2 ]
机构
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Univ Iceland, Reykjavik, Iceland
[5] Landspitali Natl Univ Hosp, Reykjavik, Iceland
关键词
DISEASE;
D O I
10.7326/L18-0245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:268 / 268
页数:1
相关论文
共 50 条
  • [31] Fibrinolysis and the risk of venous and arterial thrombosis
    Meltzer, Mirjam E.
    Doggen, Carine J. M.
    de Groot, Philip G.
    Rosendaal, Frits R.
    Lisman, Ton
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (03) : 242 - 248
  • [32] Janus kinase 2 mutation and venous thrombosis in Egyptian patients with Philadelphia negative chronic myeloproliferative neoplasms
    Morad, Mohamed A.
    Mattar, Mervat
    Ibrahim, Heba
    ElNahass, Yasser H.
    Nader, Heba
    Rawi, Rasha
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2025, 50 (01): : 38 - 44
  • [33] Cancer risk in chronic myeloproliferative neoplasms Response
    Frederiksen, Henrik
    Farkas, Dora Kormendine
    Christiansen, Christian Fynbo
    Hasselbalch, Hans Carl
    Sorensen, Henrik Toft
    BLOOD, 2012, 119 (16) : 3862 - 3863
  • [34] Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working Group
    Gutwein, Odit
    Lavi, Noa
    Barzilai, Merav
    Shacham-Abulafia, Adi
    Leader, Avi
    Chubar, Evgeni
    Dally, Najib
    Shapira, Shirley
    Mishchenko, Elena
    Ellis, Martin
    Koren-Michowitz, Maya
    ACTA HAEMATOLOGICA, 2021, 144 (04) : 438 - 445
  • [35] Erythrocytes from patients with myeloproliferative neoplasms and splanchnic venous thrombosis show greater expression of Lu/BCAM
    Novitzky-Basso, I.
    Spring, F.
    Anstee, D.
    Tripathi, D.
    Chen, F.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (04) : 473 - 477
  • [36] Cerebral venous thrombosis and myeloproliferative neoplasms: Results from two large databases
    Dentali, Francesco
    Ageno, Walter
    Rumi, Elisa
    Casetti, Ilaria
    Poli, Daniela
    Scoditti, Umberto
    Maffioli, Margherita
    di Minno, Matteo Nicola Dario
    Caramazza, Domenica
    Pietra, Daniela
    De Stefano, Valerio
    Passamonti, Francesco
    THROMBOSIS RESEARCH, 2014, 134 (01) : 41 - 43
  • [37] Splanchnic vein thrombosis (SVT) in patients with myeloproliferative (MPN) neoplasms
    Danaee, A.
    Ahmed, S.
    Patch, D.
    Sekhar, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 65 - 65
  • [38] Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
    Taniguchi, Yasuhiro
    Tanaka, Hirokazu
    Luis, Espinoza J.
    Sakai, Kazuko
    Kumode, Takahiro
    Sano, Keigo
    Serizawa, Kentarou
    Rai, Shinya
    Morita, Yasuyoshi
    Hanamoto, Hitoshi
    Tsubaki, Kazuo
    Nishio, Kazuto
    Matsumura, Itaru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (05) : 691 - 703
  • [39] Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
    Yasuhiro Taniguchi
    Hirokazu Tanaka
    Espinoza J. Luis
    Kazuko Sakai
    Takahiro Kumode
    Keigo Sano
    Kentarou Serizawa
    Shinya Rai
    Yasuyoshi Morita
    Hitoshi Hanamoto
    Kazuo Tsubaki
    Kazuto Nishio
    Itaru Matsumura
    International Journal of Hematology, 2017, 106 : 691 - 703
  • [40] Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study
    Hur, Joon Young
    Choi, Nayeon
    Choi, Jung Hye
    Kim, Jiyeong
    Won, Young-Woong
    THROMBOSIS RESEARCH, 2024, 236 : 209 - 219